Semaglutide is a medication belonging to the class of drugs known as GLP-1 (glucagon-like peptide-1) receptor agonists. It is used for chronic weight management. It works by increasing insulin production and lowering glucagon secretion as well as targeting areas in the brain that regulates appetite and food intake. A small change in the molecule allows the drug to last weeks in our bodies rather than the natural version our bodies make, which lasts minutes.
Benefits of Oral Sublingual Drops/Liquid
CONVENIENCE: Sublingual drops are easy to administer and are especially useful for patients who have an aversion to injections. The sublingual drops allow for ease of dose adjustments.
IMPROVED ABSORPTION: Sublingual administration allows the medication to be absorbed directly into the bloodstream through the mucous membranes under the tongue, bypassing the gastrointestinal tract and liver metabolism (first-pass effect).
ENHANCED PATIENT COMPLIANCE: The ease of use and the faster onset of effects can lead to better adherence to the treatment regimen.
Benefits of SubMagnaTM Vehicle Versus Other Vehicles
SUPERIOR ABSORPTION: SubMagna™, developed by PCCA, is designed to enhance the bioavailability of active pharmaceutical ingredients (specifically semaglutide) when administered sublingually. This means a higher percentage of the drug enters the bloodstream, making the treatment more effective.
STABILITY: SubMagna™ provides a stable environment for semaglutide, ensuring the medication remains effective over time without degradation.
PATIENT COMFORT: The vehicle is formulated to be gentle on the mucous membranes, reducing the risk of irritation compared to other vehicles.
COMPATIBILITY: SubMagna™ is specifically designed to be compatible with a range of active ingredients, ensuring that semaglutide maintains its efficacy when compounded in this vehicle.
OPTIMIZED DELIVERY: SubMagna™ facilitates a consistent and predictable delivery of semaglutide, ensuring that patients receive the correct dosage with each administration.
